Global Recombinant Cell Culture Supplements Industry Market Research 2030

"Recombinant cell culture supplements are mainly used for stem cell research, gene therapy and biotechnology development. These supplements and growth factors are applied to stem cells for culture expansion or to drive differentiation into specific cell types. Over time, stem cell research will continue to expand, advance and gain adoption. Major manufacturers such as Merck KGaA, Thermo Fisher Scientific, Inc. and Hoffmann-La Roche Ltd have distribution facilities, manufacturing plants and offices around the world. 

The rise of e-commerce has also made it easier for well-known companies to obtain recombinant cell culture supplements. In its new research, Persistence Market Research has in-depth understanding of the key factors driving the demand for recombinant cell culture supplements. The study pointed out that mammalian recombinant cell culture supplements are the most sought after.

 

Pharmaceutical companies account for approximately one third of the global market share. The report also tracks the global sales of recombinant cell culture supplements in more than 20 high-growth markets, and analyzes the impact of COVID-19 on the entire life science industry, especially culture supplements, especially recombinant cells. As the focus shifts to COVID-19 research and stem cell research, the demand for recombinant cell culture supplements has increased. The demand for these supplements increases during the pandemic. The supply chain crisis during the lockdown affected sales; however, sales later recovered without adversely affecting the market.

 

 What is the future demand for recombinant cell culture supplements?

In recent years, the demand for recombinant cell culture supplements has increased exponentially. In addition, the increasing focus on stem cell research and oncology research has created a portal for manufacturers of recombinant cell culture supplements. 

 

Recombinant products have cost-effective advantages in manufacturing and mass production of supplements/growth factors. Recombinant DNA technology has revolutionized the pharmaceutical methods of treatment and research-aided product development. Due to the development of new treatments and biopharmaceuticals or biological products, the market for recombinant cell culture supplements is expanding significantly. 

The rapid growth of drug discovery projects is expected to drive demand during the forecast period. The demand for biological and animal-free products is expected to change the future of the biopharmaceutical industry. All these factors are expected to create opportunities for the expansion of the market size of recombinant cell culture supplements during the forecast period. It is estimated that by 2030, the compound annual growth rate will be close to 8%.

 

How will market consolidation activities affect the demand for recombinant cell culture supplements? 

In view of market consolidation, major players are focusing on strategic acquisitions. This trend has been observed in countries in North America, Europe, and the Asia-Pacific region. 

For example, in 2017, Thermo Fisher Scientific Inc. acquired Finesse Solutions, Inc., a major player in the development of scalable control automation systems and software for biological production. Merck KGaA acquired Sigma-Aldrich in November 2015, thus becoming a major player in the recombinant cell culture supplement market.

 

Why is production investment the key to market growth? 

Manufacturers are investing in the production of cell culture media and its derivatives. Cell culture medium is the most important component in the development and production of biological manufacturing and therapeutic products. Cell culture supplements such as cytokines, growth factors, amino acids, vitamins, fatty acids and lipids have been developed to support the growth of various cell lines. Manufacturers are focusing on expanding production facilities to achieve For example, in 2018, GE Healthcare Life Science announced an increase in the annual production capacity of cell culture media and supplements. In July 2019, FUJIFILM Irvine Scientific announced the construction of new cell culture production bases for cell culture in the Netherlands and Europe. FUJIFILM Irvine Scientific has 3 production facilities in the fields of biological production, cell therapy and gene therapy. It is expected that during the forecast period, increased investment and expansion of manufacturing capacity will support the growth of the growth factor market.

 

What impact does the emergence of the Institute of Basic Research have on recombinant cell culture supplements? 

Academic research institutions focus on advancing basic research, which also includes applied research. On the other hand, governments or industry organizations prefer a cost-effective way of following development plans. Most basic research continues to be conducted in academia as the company focuses on bringing products to the market to generate profits. According to a 2012 report by the National Science Foundation, 56% of basic research in the United States is conducted in academia, while 61% of applied research and 87% of development occur in industry. Research laboratories ensure that they continue to be the most trusted group to carry out basic research programs.

 

Will the growing demand for regenerative medicine drive the sales of recombinant cell culture supplements? 
Regenerative medicine is a part of medicine that involves the process of repairing, replacing or regenerating cells, tissues or organs with birth defects, aging, disease or damage. Recombinant cell culture supplements provide biochemical clues for stem cell isolation and are used to formulate unique strategies for the treatment of human diseases by examining the cellular processes that control tissue development, aging and regeneration. 

Regulating growth factors at the injured site is one of the strategies to stimulate tissue regeneration. Growth factors play an important role in the regeneration of blood vessels and hematopoietic, nerve, bone, pancreas, periodontal and mucosal tissues. Recombinant growth factors, such as platelet-derived growth factor and bone morphogenetic factors, are increasingly in demand for tissue regeneration in diabetic neuropathic ulcers and periodontal defects, tibial fractures and nonunion sites, and tissue regeneration in the case of tibial nonunion Higher. The growing demand for recombinant cell culture supplements in regenerative medicine and gene therapy research projects is expected to drive market growth in the next few years.

 

Category Insight: 

How does the growing demand for animal-free recombinant cell culture supplements affect the industry? 
As the demand for these products increases, manufacturers are focusing on bringing non-animal recombinant cell culture supplements to the market. Non-animal products eliminate the risk of contaminating cell culture media. Non-animal products are manufactured using a fully humanized production system. Animal-derived cells are not used to make these types of cytokines and growth factors. Animal-free recombinant cell culture supplements do not contain animal components, serum, endotoxin and endogenous mammalian contamination. 

Therefore, animal-free recombinant cell culture supplements do not contain contaminants. Product portfolio. For example, Applied Biological Materials Inc., Peprotech, Cell Application Inc., AMS Biotechnology (Europe) Limited, Gemini Bio Products produce animal-free growth factors. Animal growth factor-free and recombinant cell culture supplements have been widely used in various studies and are expected to promote the growth of the global recombinant cell culture supplement market in the next few years.

 

Competitive landscape: 

The recombinant cell culture supplement market is highly mature in nature, with more than 10 major players in the market. The global market is dominated by leading manufacturers: Thermo Fisher Scientific Inc., Merck KGaA and Becton, Dickinson and Company, Lonza and Hi-Media Laboratories. Most of these manufacturers focus on providing a wide range of recombinant cell culture supplements for a variety of applications, such as stem cell research, oncology research, and bioprocessing. Manufacturers focus on R&D activities, such as the application of recombinant cell culture supplements in various clinical and research fields. Therefore, market participants are also committed to expanding their global and regional influence through acquisition and expansion strategies. 

In November 2015, the Merck Group acquired Sigma-Aldrich, and this acquisition helped the two companies become the worlds leading providers of life science solutions. In 2015, Abcam signed a cooperation agreement with the A​​-STAR Institute of Cell and Molecular Biology to produce high-quality lifetime immunoassays. 
In October 2018, Thermo Fisher Scientific acquired the advanced bioprocessing business of the world leading medical technology company BD (Becton, Dickinson and Company). Some of the leading companies operating in the market are: Thermo Fisher Scientific Inc. Merck KGaALonzaAbcam PLC. Hi-Media Laboratories Becton, Dickinson and CompanySTEMCELL Technologies Inc. Fujifilm Corporation (Irvine Scientific) Biocon.
 

Geography Analysis:

The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

• North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
• Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
• Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
• Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
• Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.